CA Stock MarketDetailed Quotes

AVCN Avicanna Inc

Watchlist
  • 0.335
  • +0.015+4.69%
15min DelayMarket Closed Dec 17 16:00 ET
36.71MMarket Cap-3.60P/E (TTM)

About Avicanna Inc Company

Avicanna Inc is an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products for the global consumer, as well as medical and pharmaceutical market segments. In global cannabinoid advancements, it conducts most of its research in Canada at its research and development headquarters in JLABS in Toronto, located in the MaRS Discovery District. The company actively collaborates with Canadian academic and medical institutions. Avicanna has established a scientific platform including research and development and clinical development which led to the commercialization of more than twenty products across four main market segments.

Company Profile

SymbolAVCN
Company NameAvicanna Inc
Founded2016
MarketTSE
Employees38
Fiscal Year Ends12-31
Address480 University Avenue Suite 1502
CityToronto
CountryCAN
Zip CodeM5G 1V2
Phone+1 647 243-5283

Company Executives

  • Name
  • Position
  • Salary
  • Aras Azadian
  • Director and Chief Executive Officer
  • --
  • Stephen Kim
  • Chief Legal Officer, General Counsel and Corporate Secretary of Avicanna USA Inc
  • --
  • Phillip Cardella
  • Chief Financial Officer
  • --
  • Giancarlo Davila Char
  • Director
  • --
  • Eileen McCormack
  • Independent Director
  • --
  • Paul Fornazzari
  • Independent Director
  • --
  • John McVicar
  • Independent Director
  • --